Clinical Gastroenterology & Hepatology
Medical
An engaging mix of author interviews and expert commentary on the latest articles from Clinical Gastroenterology and Hepatology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.
Location:
United States
Description:
An engaging mix of author interviews and expert commentary on the latest articles from Clinical Gastroenterology and Hepatology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.
Language:
English
Episodes
Development of Fecal Microbiota Transplantation
4/2/2015
An article in the February issue of CGH looks at solutions to issues concerning fecal microbiota transplantation, and challenges involving this increasingly common procedure that still remain. Dr. Kuemmerle speaks with author Dr. Alexander Khoruts.
Duration:00:17:36
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients
4/2/2015
A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease.
Duration:00:14:18
Gastrointestinal Bleeding After Implantation of Ventricular Assist Devices
2/13/2015
An article in the January issue of CGH investigated the incidence, etiology, and outcome of GI bleeding in patients with ventricular assist devices. Dr. Kuemmerle speaks to co-author Dr. John Vargo of the Cleveland Clinic.
Duration:00:14:36
Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
11/26/2014
A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis.
Duration:00:15:20
How Gastroenterologists Can Demonstrate Value
10/15/2014
An AGA Board Strategic Update article in the October issue of CGH discusses recent changes to how a gastroenterologist demonstrates value in the era of the Affordable Care Act. Dr. Kuemmerle speaks to Dr. Lawrence Kosinski.
Duration:00:19:24
Restarting Infliximab in IBD Patients with Prior Loss of Response
9/8/2014
An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.
Duration:00:17:31
Evolution of Hepatitis C Virus Treatment
8/4/2014
An editorial in the August issue of CGH discusses changing treatment methods for Hepatitis C Virus infection over the last several years. Dr. Kuemmerle speaks to first author Dr. Fasiha Kanwal of Baylor College of Medicine.
Duration:00:16:36
Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients
7/2/2014
An article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to Dr. Kathleen Corey
Duration:00:11:02
PPIs and NSAID–Related Lower Gastrointestinal Adverse Events
6/11/2014
A commentary in the June issue of CGH looks at the effect of proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) on the lower gastrointestinal tract. Dr. Kuemmerle speaks to author Dr. Francis KL Chan.
Duration:00:13:43
History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome
5/1/2014
A review article in the May issue of CGH looks at the major advances in risk assessment, molecular genetics, DNA mutational analyses, and cancer prevention and management of Lynch syndrome over the last 100 years; with guest Dr. Fay Kastrinos
Duration:00:17:33
Prevalence of Eosinophilic Esophagitis in the U.S.
4/2/2014
Eosinophilic esophagitis (EoE) has become a major cause of upper gastrointestinal morbidity in children and adults. A study in the April issue of CGH estimates the prevalence of EoE in the United States. Dr. Kuemmerle speaks to author Dr. Evan S. Dellon
Duration:00:15:44
DNA Testing and Molecular Screening for Colon Cancer
3/21/2014
An “Advances in Translational Science” article in the March issue of CGH looks at the future of DNA testing and molecular screening for colon cancer. Dr. Kuemmerle speaks with author Dr. John M. Carethers of the University of Michigan Dept of Medicine
Duration:00:24:47
New Anticoagulant and Antiplatelet Agents
2/4/2014
An article in the February issue of CGH offers a primer for gastroenterologists on the use of new anticoagulant and antiplatelet agents. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes
Duration:00:24:01
A Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy
1/13/2014
A phase 2 study in the January 2014 issue of CGH investigated the efficacy of allogeneic mesenchymal stromal cells in patients with luminal Crohn's disease. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes
Duration:00:17:22
Reconsidering Diverticular Disease
12/3/2013
A study in the December CGH finds that constipation and a low-fiber diet are not associated with diverticulosis. A related "Perspectives in Clinical Gastroenterology and Hepatology" article reconsiders conventional wisdom about diverticular disease.
Duration:00:11:42
Interpretation and Management of Hepatic Abnormalities in Pregnancy
11/5/2013
A review in the November issue of CGH provides a practical guide to evaluation and management of pregnant patients with abnormal liver chemistries or function. Dr. Kuemmerle speaks to Dr. Mary E. Rinella
Duration:00:16:36
Bile Acid Malabsorption in the Colon
10/3/2013
Two related articles appear in the October issue of CGH: "Methods for Diagnosis of Bile Acid Malabsorption in Clinical Practice” and “Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With IBS.”
Duration:00:16:25
Coagulation in Liver Disease: A Guide for the Clinician
9/7/2013
An article in the September issue of CGH summarizes the pathophysiology of hemostasis in liver disease, describes pros and cons of lab tests for those patients, and outlines the optimal management of hemostasis for various clinical scenarios.
Duration:00:25:02
Internet Liability for Gastroenterologists
8/1/2013
An article in the August CGH discusses the dangers and advantages physicians should consider when utilizing the internet and social media in their medical practices or private communications. Dr. Kuemmerle speaks to Dr. Andrew D. Feld.
Duration:00:20:48
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Nonalcoholic Fatty Liver Patients
7/5/2013
A study in the July issue of CGH compares the colonic microbiome and volatile organic compound metabolome of obese nonalcoholic fatty liver disease patients with that of healthy-weight individuals. Dr. Kuemmerle speaks to author Dr. Kevin P. Rioux.
Duration:00:16:45